Hanyu Pharmaceutical announced that the company has received a purchase order from the US partner Hikma, and it plans to purchase liraglutide injections from the company (USD 117.36 million).

Zhitongcaijing · 10/17 10:25
Hanyu Pharmaceutical announced that the company has received a purchase order from the US partner Hikma, and it plans to purchase liraglutide injections from the company (USD 117.36 million).